Alzheimer's Disease: Differences of Transdermal versus Oral Treatment on Caregiving Time.
about
Comparison of the effects of transdermal and oral rivastigmine on cognitive function and EEG markers in patients with Alzheimer's disease.Rivastigmine transdermal patch 13.3 mg/24 h: a review of its use in the management of mild to moderate Alzheimer's dementia.[Users and utilization of support groups among caregivers of dementia patients : Results of a naturalistic observational study].Alpha rhythm oscillations and MMSE scores are differently modified by transdermal or oral rivastigmine in patients with Alzheimer's disease.
P2860
Alzheimer's Disease: Differences of Transdermal versus Oral Treatment on Caregiving Time.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Alzheimer's Disease: Differences of Transdermal versus Oral Treatment on Caregiving Time.
@ast
Alzheimer's Disease: Differences of Transdermal versus Oral Treatment on Caregiving Time.
@en
type
label
Alzheimer's Disease: Differences of Transdermal versus Oral Treatment on Caregiving Time.
@ast
Alzheimer's Disease: Differences of Transdermal versus Oral Treatment on Caregiving Time.
@en
prefLabel
Alzheimer's Disease: Differences of Transdermal versus Oral Treatment on Caregiving Time.
@ast
Alzheimer's Disease: Differences of Transdermal versus Oral Treatment on Caregiving Time.
@en
P2093
P2860
P356
P1476
Alzheimer's Disease: Differences of Transdermal versus Oral Treatment on Caregiving Time.
@en
P2093
H Reichmann
H-U Wittchen
J Klotsche
P2860
P304
P356
10.1159/000342929
P50
P577
2012-01-01T00:00:00Z